SCHEMBL31411771

SCHEMBL31411771

Nc1ccc2c(c1)N(CC1CN(c3ccccc3)C1)C(=O)CS2

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ MAPT P10636 5/20 0.37
▸ SIGMAR1 Q99720 1/20 0.37
▸ TSHR P16473 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ POLB P06746 2/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ GFER P55789 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31411660 0.84 LMNA (0.52) ALDH1A1CYP2C9CYP2C19MAPTTSHR
SCHEMBL31411690 0.80 SMN1; SMN2 (0.55) ALDH1A1CYP2C9CYP2C19MAPTTSHR
SCHEMBL31411613 0.78 ALDH1A1 (0.44) ALDH1A1CYP2C9CYP2C19MAPTTSHR
SCHEMBL23768993 0.77 ALDH1A1 (0.57) ALDH1A1CYP2C9CYP2C19MAPTSIGMAR1
SCHEMBL29979053 0.77 ALDH1A1 (0.57) ALDH1A1CYP2C9CYP2C19MAPTSIGMAR1
SCHEMBL31411724 0.74 MAPT (0.44) ALDH1A1MAPTTSHRLMNASMN1; SMN2
SCHEMBL31411648 0.73 MAPT (0.41) ALDH1A1CYP2C9CYP2C19MAPTTSHR
SCHEMBL31411799 0.73 CRHR1 (0.38) ALDH1A1MAPTSIGMAR1LMNAMAPK1
SCHEMBL31411607 0.72 STING1 (0.44) ALDH1A1MAPTTSHRLMNASMN1; SMN2
SCHEMBL15651575 0.70 ALDH1A1 (0.38) ALDH1A1CYP2C9CYP2C19SIGMAR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119330982-A Azetidine compound and medical application thereof 中国科学院上海药物研究所 2025-01-21 — — CN disclosed
Send feedback